Alnylam Pharmaceuticals
ALNY
#571
Rank
ยฃ30.70 B
Marketcap
ยฃ231.52
Share price
-1.18%
Change (1 day)
23.20%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company